- 3 次围观
产品图片
货号/SKU
NR-469
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、2
产品描述信息
NR-469??Junin virus, Candid #1(Viruses)|Junin virus|Candid #1|-60°C or colder|CH CalisherAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Junín Virus, Candid #1, NR-469.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Junin virus (JUNV), Candid #1 is a vaccine strain that was developed in the late 1980s from JUNV, XJ, which was isolated from the first human infections with JUNV, the causative agent of Argentine Hemorrhagic Fever (AHF). The heavily attenuated vaccine strain, Candid #1, was developed through collaboration by United States Army Medical Research Institute of Infectious Diseases (USAMRIID), the Argentinian government and the US National Institutes of Health (NIH) by attenuation through serial passage in guinea pigs, mice and FRhK cells.
The complete genomes of JUNV, Candid #1 segments L and S have been sequenced (GenBank: AY819707 and FJ969442). In order to remove contaminating mycoplasma, the first three viral passages at BEI Resources were performed with Plasmocin? (InvivoGen), followed by three passages without Plasmocin?.
Each vial contains approximately 1 mL of cell lysate and supernatant from Cercopithecus aethiops kidney cells infected with JUNV, Candid #1.
Additional information and tools are available at ViPR (Virus Pathogen Resource).
Junin virus (JUNV), Candid #1 is a vaccine strain that was developed in the late 1980s from JUNV, XJ, which was isolated from the first human infections with JUNV, the causative agent of Argentine Hemorrhagic Fever (AHF). The heavily attenuated vaccine strain, Candid #1, was developed through collaboration by United States Army Medical Research Institute of Infectious Diseases (USAMRIID), the Argentinian government and the US National Institutes of Health (NIH) by attenuation through serial passage in guinea pigs, mice and FRhK cells.
The complete genomes of JUNV, Candid #1 segments L and S have been sequenced (GenBank: AY819707 and FJ969442). In order to remove contaminating mycoplasma, the first three viral passages at BEI Resources were performed with Plasmocin? (InvivoGen), followed by three passages without Plasmocin?.
Each vial contains approximately 1 mL of cell lysate and supernatant from Cercopithecus aethiops kidney cells infected with JUNV, Candid #1.
Additional information and tools are available at ViPR (Virus Pathogen Resource).
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.在此限制上订单将在发货前发送到NIAID进行批准. Junin病毒（junv），Candid＃1是一个疫苗菌株，该疫苗在20世纪80年代后期从junv，XJ的疫苗中开发，XJ是从第一次人类感染junv，阿根廷出血热的致病剂（ahf）.通过美国陆军医学研究所（USAMRIID），阿根廷政府和美国国立卫生研究院（NIH）通过豚鼠的串行通道，通过由豚鼠的连续通道进行序列，通过合作开发了重症的疫苗菌株小鼠和frhk细胞.
junv的完整基因组，Candid＃1段L和S已被测序（GenBank： AY819707 和 fj969442 ）.为了去除污染支原体，使用Plasmocin TM（InvivoCoL）进行BEI资源的前三个病毒通道，然后进行三个没有Plasmocin TM的通道.
每个小瓶含有大约1ml的细胞裂解物和来自 Cercopithecus Aethiops的上清液感染Junv，Candid＃1的肾细胞.
vipr （病毒病原体资源）提供了附加信息和工具.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2021-12-21
2021-12-02
2024-06-22
2022-03-31
2022-04-01
2023-11-14
2021-12-21
2022-04-01
2022-04-01
2021-12-21
2023-10-21
2021-12-21
2022-06-17
2022-04-01
2024-08-16